Stockchase Opinions

Werner Muehelemann Allon Therapeutics Inc. NPC-T COMMENT May 28, 2008

Main technology is trying to develop a drug for Alzheimer's. Have had good success to now. Still not a commercial product so there is still a lot of risk. Good potential. Has been looking at this one.
$1.050

Stock price when the opinion was issued

medical services
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
are in phase 2 and 3 testing for some drugs. Gotta be willing to be patient on it. Take small positions, be prepared if their testing doesn't work out to loose your money.